Israel’s battlefield medical advances have helped reduce the reported combat mortality rate from 15% during the 2006 Lebanon War to 7.1% in 2023, drawing growing interest from the US military.
By Hezy Laing
Israel has transformed the way it treats wounded soldiers on the battlefield, bringing advanced medical care closer to the fighting and improving the chances that seriously injured troops will survive.
According to IDF figures, the reported combat mortality rate fell from 15% during the 2006 Second Lebanon War against Hezbollah to 7.1% in 2023. The improvement reflects a broader evolution in battlefield medicine, including faster treatment, better control of severe bleeding, and more effective casualty evacuation.
The lessons are attracting attention from the US military, which is studying Israel’s experience treating wounded troops during intense combat in Gaza and on multiple fronts.
Medical Care Within Minutes
One of the most important changes is how quickly advanced medical treatment can reach wounded soldiers. During the 2006 Lebanon War, advanced life support could take 15 to 20 minutes to arrive. An IDF medical specialist told Fox News Digital that today, medical care can reach casualties immediately or within four minutes.
The IDF has moved medical personnel closer to combat troops, including assigning doctors to fighting companies. This allows physicians and paramedics to begin treating life-threatening injuries earlier, rather than waiting for casualties to reach a rear medical facility.
Rapid evacuation is another essential part of the system. Helicopters and specialized medical vehicles transport seriously wounded soldiers to Israeli hospitals, where surgical teams can provide the treatment needed to stabilize them and repair severe injuries.
The goal is to shorten the time between injury and effective treatment, particularly when a soldier is suffering from major blood loss or other immediately life-threatening trauma.
Blood Products Can Make the Difference
Severe bleeding is one of the leading causes of preventable battlefield death. Israel has therefore invested in getting blood products and bleeding-control treatments to wounded soldiers as quickly as possible.
The IDF introduced freeze-dried plasma and other treatments before the current war. Since the fighting began in October 2023, it has also expanded the use of low-titer group O whole blood in appropriate circumstances. This type of blood can be administered to eligible casualties without first determining their exact blood group, subject to medical protocols and compatibility safeguards.
Medical teams carry blood supplies closer to the front, including aboard some armored evacuation vehicles. This allows them to begin replacing lost blood and supporting circulation while transporting casualties for further treatment.
These capabilities are particularly important because a soldier with catastrophic blood loss may deteriorate rapidly before reaching a hospital. Controlling bleeding and providing appropriate blood products early can help keep that soldier alive long enough for surgeons to intervene.
A peer-reviewed 2015 study of IDF casualties found that changes in battlefield medical care, including forward medical personnel and improved treatment for severe bleeding, were associated with lower mortality during the 2014 Gaza conflict than in 2006.
Why the US Army Is Studying Israel
American interest in Israeli battlefield medicine predates the current war. In April 2024, a multinational trauma research delegation that included a US Army Reserve physician visited Israel to study how the IDF treats combat casualties.
A US Army lessons-learned report published in April 2026 also examined Israel’s wartime medical experience. The broader lesson is that saving lives requires more than skilled doctors: military organizations must position medical teams effectively, maintain reliable supplies, coordinate evacuations, and adapt procedures to the conditions troops face.
These lessons matter to the US military as it prepares for the possibility of large-scale conflicts in which evacuation routes may be dangerous, transport may be delayed, and hospitals may be far from the battlefield.
Israel’s experience offers practical examples of how medical care can be integrated into combat operations rather than treated as something that begins only after a wounded soldier leaves the front line.
A Continuing Medical Revolution
Israel’s battlefield experience demonstrates that survival depends on more than the quality of hospital surgery. The speed of treatment, the availability of blood, the positioning of medical personnel, and coordination between teams can all influence whether a wounded soldier survives.
For the IDF, the mission is to give wounded soldiers the best possible chance of survival, even under the most dangerous conditions. By bringing lifesaving treatment closer to the front, controlling bleeding quickly, and evacuating casualties without unnecessary delay, Israeli military medicine is helping turn more battlefield injuries into survivable ones.
